MPO and colitis: Our study shows that therapy by 5-ASA, as expected, obviously attenuated the severity of colitis in mice, including decrease DAI, increase colon length and alleviate the damage of colonic mucosal, furthermore, showed anti-inflammatory effects that suppressed proinflammatory mediators of MPO, IL-1β and TNF-α.